⟨/⟩ AT Protocol Record Source
at://did:plc:mg2rdtpeh5ijpdv5raeplvz7/site.standard.document/3mnsdpbwbjl22
← Back to post
{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieodio53thiodjmrtsf553rur4eefboeyaqlqrbevr5s5tqxzkqzi",
    "uri": "at://did:plc:mg2rdtpeh5ijpdv5raeplvz7/app.bsky.feed.post/3mnsdpbwbif22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiadwbqygjjd6go5jeju273l6e2lrnculq6w55amgcatewiwgk2jvm"
    },
    "mimeType": "image/png",
    "size": 391262
  },
  "path": "/doliprane-latecoere-exxelia-la-lente-vente-des-bijoux-industriels-francais/",
  "publishedAt": "2026-06-08T17:08:12.000Z",
  "site": "https://zoesagan.com",
  "tags": [
    "gossip-brief",
    "economie"
  ],
  "textContent": "Opella et son Doliprane a CD&R, Latecoere a Searchlight, Exxelia a Heico : des fleurons strategiques passent sous pavillon americain. Selon le London Stock Exchange Group, plus de 1600 entreprises francaises depuis 2014.",
  "title": "Doliprane, Latécoère, Exxelia : la lente vente des bijoux industriels français"
}